Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply.

Wenger JD, Zulz T, Bruden D, Singleton R, Bruce MG, Bulkow L, Parks D, Rudolph K, Hurlburt D, Ritter T, Klejka J, Hennessy T.

Pediatr Infect Dis J. 2010 Mar;29(3):251-6. doi: 10.1097/INF.0b013e3181bdbed5.

PMID:
19952861
3.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

4.

Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region.

Lin TY, Shah NK, Brooks D, Garcia CS.

Vaccine. 2010 Nov 10;28(48):7589-605. doi: 10.1016/j.vaccine.2010.07.053. Epub 2010 Aug 1. Review.

PMID:
20674872
5.

[Heptavalent-pneumococcal conjugate vaccine (Prevenar). Differences in effectiveness between populations].

Guevara M, Barricarte A, Pérez B, Arriazu M, García Cenoz M, Castilla J.

An Sist Sanit Navar. 2008 May-Aug;31(2):171-92. Review. Spanish.

6.

Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines.

Ansaldi F, de Florentis D, Canepa P, Bandettini R, Diana MC, Martini M, Durando P, Icardi G.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:211-6. doi: 10.4161/hv.7.0.14602. Review.

PMID:
21546795
7.

Global prevailing and emerging pediatric pneumococcal serotypes.

McIntosh ED, Reinert RR.

Expert Rev Vaccines. 2011 Jan;10(1):109-29. doi: 10.1586/erv.10.145. Review.

PMID:
21162625
8.

Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.

Shibl A, Memish Z, Pelton S.

Int J Antimicrob Agents. 2009 May;33(5):410.e1-9. doi: 10.1016/j.ijantimicag.2008.08.012. Epub 2008 Oct 30. Review.

PMID:
18976887
9.

Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.

Picazo JJ.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Review.

10.
11.

Improving the protection against Streptococcus pneumoniae with the new generation 13-valent pneumococcal conjugate vaccine.

Durando P, Alicino C, De Florentiis D, Martini M, Icardi G.

J Prev Med Hyg. 2012 Jun;53(2):68-77. Review.

PMID:
23240163
12.

Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: an evaluation using existing data.

Picón T, Alonso L, García Gabarrot G, Speranza N, Casas M, Arrieta F, Camou T, Rosa R, De Oliveira LH, Verani JR.

Vaccine. 2013 Jul 2;31 Suppl 3:C109-13. doi: 10.1016/j.vaccine.2013.01.059. Review.

PMID:
23777683
13.

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children.

Hausdorff WP, Siber G, Paradiso PR.

Lancet. 2001 Mar 24;357(9260):950-2. Review.

PMID:
11289365
14.

[Pneumococcal vaccine].

Ishiwada N.

Nihon Rinsho. 2011 Sep;69(9):1584-8. Review. Japanese.

PMID:
21922757
15.

Pneumococcal disease and use of pneumococcal vaccines in Taiwan.

Wei SH, Chiang CS, Chen CL, Chiu CH.

Clin Exp Vaccine Res. 2015 Jul;4(2):121-9. doi: 10.7774/cevr.2015.4.2.121. Epub 2015 Jul 29. Review.

16.

Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature.

Segal N, Greenberg D, Dagan R, Ben-Shimol S.

Vaccine. 2016 Aug 17;34(37):4371-7. doi: 10.1016/j.vaccine.2016.07.004. Epub 2016 Jul 18. Review.

PMID:
27443591
17.

Global Burden of Neonatal Invasive Pneumococcal Disease: A Systematic Review and Meta-analysis.

Billings ME, Deloria-Knoll M, O'Brien KL.

Pediatr Infect Dis J. 2016 Feb;35(2):172-9. doi: 10.1097/INF.0000000000000955. Review.

PMID:
26517330

Supplemental Content

Support Center